NIH Locks Down Meeting on Early-Life HIV Research Funding
Published Date: 3/20/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 24, 2025, to review grant applications focused on early-life HIV immunity research. This meeting affects researchers applying for funding and keeps sensitive information private. The decisions made could impact future funding and scientific progress in fighting HIV.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Clinical Trials Excluded from U01 Funding
The MIEL funding opportunity is a U01 mechanism where clinical trials are not allowed (listed as "U01 Clinical Trial Not Allowed"). If you are a researcher planning to propose a clinical trial, you cannot use this U01 solicitation for that work.
Closed Grant Review Protects Applicants' Privacy
The National Institute of Allergy and Infectious Diseases will hold a closed meeting on April 24, 2025 to review grant applications for the Mechanisms of Inducing HIV Immunity in Early Life (MIEL) U01 program. The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information of applicants.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-04666 — National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings
The National Institute of Neurological Disorders and Stroke is holding two secret virtual meetings on April 10, 2025, to review important grant applications. These closed sessions protect private info and trade secrets while deciding who gets funding to advance brain research. Scientists and companies applying for grants should watch for results soon, as these decisions impact future neurological studies and funding.
Next: 2025-04668 — National Institute of Mental Health; Notice of Closed Meeting
The National Institute of Mental Health is holding a private virtual meeting on April 22-23, 2025, to review and decide on mental health research grant applications. This meeting affects researchers seeking funding and keeps sensitive info safe. It’s a key step in choosing who gets money to improve mental health treatments.